Insider Selling: Revvity (NYSE:RVTY) CAO Sells $13,060.32 in Stock

by · The Cerbat Gem

Revvity Inc. (NYSE:RVTY – Get Free Report) CAO Anita Gonzales sold 84 shares of the company’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $155.48, for a total transaction of $13,060.32. Following the sale, the chief accounting officer directly owned 7,117 shares in the company, valued at approximately $1,106,551.16. This trade represents a 1.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Anita Gonzales also recently made the following trade(s):

  • On Monday, July 20th, Anita Gonzales sold 85 shares of Revvity stock. The stock was sold at an average price of $109.48, for a total transaction of $9,305.80.

Revvity Price Performance

RVTY opened at $151.46 on Monday. The firm has a 50-day moving average price of $128.26 and a 200-day moving average price of $108.85. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $158.28. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $16.90 billion, a price-to-earnings ratio of 72.13, a PEG ratio of 2.76 and a beta of 1.06.

Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. During the same period in the prior year, the company posted $1.18 EPS. Revvity’s revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities analysts expect that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s payout ratio is 13.33%.

Institutional Investors Weigh In On Revvity

Several large investors have recently added to or reduced their stakes in the business. QRG Capital Management Inc. increased its stake in Revvity by 14.4% in the 2nd quarter. QRG Capital Management Inc. now owns 5,881 shares of the company’s stock worth $654,000 after acquiring an additional 742 shares during the last quarter. State Street Corp raised its holdings in shares of Revvity by 0.8% in the 2nd quarter. State Street Corp now owns 4,342,739 shares of the company’s stock valued at $483,173,000 after acquiring an additional 32,426 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Revvity by 5.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 368,938 shares of the company’s stock valued at $41,048,000 after acquiring an additional 20,278 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Revvity during the 2nd quarter valued at about $171,000. Finally, Nykredit A S purchased a new position in shares of Revvity during the second quarter worth about $358,000. Institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on RVTY. Royal Bank Of Canada started coverage on Revvity in a report on Tuesday, September 1st. They set a “sector perform” rating and a $135.00 price objective on the stock. Wall Street Zen cut Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Weiss Ratings raised shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. Sanford C. Bernstein assumed coverage on shares of Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price target on the stock. Finally, Zacks Research upgraded shares of Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $116.57.

View Our Latest Report on RVTY

Revvity Company Profile

(Get Free Report)

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.

Recommended Stories